Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
2(50.0%)
N/A
2(50.0%)
4Total
Early Phase 1(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07191860Not ApplicableNot Yet Recruiting

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis

Role: lead

NCT07290140Not ApplicableNot Yet Recruiting

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Role: lead

NCT05883462Early Phase 1Active Not Recruiting

Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH)

Role: lead

NCT05895305Early Phase 1Active Not Recruiting

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis

Role: lead

All 4 trials loaded